What does CUSIP 4525EP101 represent in this 13F holders report?

CUSIP 4525EP101 is the security identifier for IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value in Q1 2026?

71 institutional investors reported IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value for Q1 2026. Use the holders table for investor-level position and value details.

IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

CUSIP: 4525EP101

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 130,556,701
Total 13F shares: 57,083,968
Share change: +12,117,298
Total reported value: $63,376,486
Put/Call ratio: 22%
Price per share: $1.11
Number of holders: 71
Value change: +$14,975,211
Number of buys: 45
Number of sells: 22

Quarterly Holders Quick Answers

What is CUSIP 4525EP101?
CUSIP 4525EP101 identifies IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 4525EP101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Vivo Opportunity Fund Holdings, L.P.	13D/G	—	10%	29,126,906	$17,767,413	$0	17 Feb 2026	13D/G
Avidity Partners Management LP	13D/G 13F	Company	9.9%	13,958,410	$15,493,835	+$10,277,489	17 Feb 2026	13D/G 13F
Deep Track Capital, LP	13D/G	—	8.7%	11,454,000	$9,964,980	$0	17 Feb 2026	13D/G
Adage Capital Management, L.P.	13D/G	—	10%	10,479,337	$8,697,850	+$7,537,012	30 Jun 2025	13D/G
JANUS HENDERSON GROUP PLC	13D/G	—	10%	12,016,444	$8,531,675	+$6,622,427	28 Nov 2025	13D/G
BIOTECHNOLOGY VALUE FUND L P	13D/G	BVF PARTNERS L P/IL	10%	13,630,601	$8,314,667	+$2,345,708	12 Feb 2026	13D/G
Commodore Capital LP	13D/G	—	9.9%	13,350,121	$8,143,574	$0	17 Feb 2026	13D/G
Alyeska Investment Group, L.P.	13D/G	—	4.8%	6,332,000	$7,345,120	-$1,354,880	31 Mar 2026	13D/G
Nantahala Capital Management, LLC	13D/G 13F	Company	8.2%	10,378,406	$7,057,316	-$174,188	31 Dec 2025	13D/G 13F
Trails Edge Capital Partners, LP	13D/G	—	8.7%	11,454,000	$6,986,940	$0	17 Feb 2026	13D/G
VANGUARD GROUP INC	13D/G 13F	The Vanguard Group · Company	4.4%	3,923,763	$4,473,090	$0	31 Dec 2024	13D/G 13F
Aberdeen Group plc	13D/G 13F	Company	6.8%	8,243,941	$4,399,791	$0	31 Dec 2025	13D/G 13F
Soleus Capital Master Fund, L.P.	13D/G	—	5.5%	6,792,000	$4,143,120	$0	17 Feb 2026	13D/G
BVF INC/IL	13F	Company	5.9%	7,652,972	$4,084,391	—	31 Dec 2025	13F
Focus Partners Wealth	13F	Company	2%	2,622,462	$2,291,863	—	31 Dec 2025	13F
Laurion Capital Management LP	13F	Company	3%	3,882,162	$2,071,910	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	2.6%	3,419,299	$1,824,880	—	31 Dec 2025	13F
Soleus Private Equity Fund III, L.P.	13D/G	Soleus Capital Management, L.P.	1.6%	1,580,007	$1,392,934	$0	30 Sep 2025	13D/G
RTW INVESTMENTS, LP	13D/G	—	1.1%	1,026,762	$1,170,509	$0	31 Mar 2025	13D/G
MORGAN STANLEY	13F	Company	1.6%	2,091,011	$1,115,973	—	31 Dec 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.1%	1,398,600	$746,433	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.9%	1,176,285	$627,944	—	31 Dec 2025	13F
683 Capital Management, LLC	13D/G	—	3.4%	474,200	$550,072	-$8,149,928	31 Mar 2026	13D/G
MARSHALL WACE, LLP	13F	Company	0.78%	1,019,983	$540,592	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	0.55%	717,470	$382,913	—	31 Dec 2025	13F
Ikarian Capital, LLC	13F	Company	0.52%	674,662	$360,067	—	31 Dec 2025	13F
Daniel Vitt	3/4/5	CEO and Director, Director	— mixed-class rows	2,809,877 mixed-class rows	$352,548	+$11,550	16 Jul 2025	3/4/5
UBS Group AG	13F	Company	0.41%	537,118	$286,822	—	31 Dec 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.4%	527,455	$282,000	—	31 Dec 2025	13F
BVF PARTNERS L P/IL	3/4/5	Director, Other*	0.33%	427,629	$260,853	—	17 Feb 2026	3/4/5
Squarepoint Ops LLC	13F	Company	0.27%	352,875	$188,329	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.26%	333,829	$178,165	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.25%	331,945	$177,159	—	31 Dec 2025	13F
Richard A. Rudick	3/4/5	Director	— mixed-class rows	480,375 mixed-class rows	$161,055	+$100,024	05 Jun 2025	3/4/5
Connective Capital Management, LLC	13F	Company	0.23%	301,296	$160,802	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.22%	286,677	$153,000	—	31 Dec 2025	13F
Joerg Neermann	3/4/5	Director	— mixed-class rows	450,000 mixed-class rows	$152,000	+$76,700	05 Jun 2025	3/4/5
CITADEL ADVISORS LLC	13F	Company	0.2%	266,806	$142,394	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.17%	225,271	$120,227	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.17%	220,727	$117,802	—	31 Dec 2025	13F
Seven Fleet Capital Management LP	13F	Company	0.12%	155,223	$82,843	—	31 Dec 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.1%	130,585	$69,693	—	31 Dec 2025	13F
Glenn Whaley	3/4/5	Chief Financial Officer	— mixed-class rows	879,010 mixed-class rows	$68,079	+$32,076	16 Jul 2025	3/4/5
Strategies Wealth Advisors, LLC	13F	Company	0.08%	100,000	$53,370	—	31 Dec 2025	13F
HB Wealth Management, LLC	13F	Company	0.07%	91,450	$48,807	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.06%	76,186	$40,660	—	31 Dec 2025	13F
LPL Financial LLC	13F	Company	0.04%	58,050	$30,981	—	31 Dec 2025	13F
Duane Nash	3/4/5	Executive Chairman, Director	— mixed-class rows	921,032 mixed-class rows	$30,075	+$16,694	16 Jul 2025	3/4/5
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	40,000	$21,348	—	31 Dec 2025	13F
Creative Planning	13F	Company	0.03%	35,000	$18,680	—	31 Dec 2025	13F

Institutional Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q1 2026

As of 31 Mar 2026, IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,083,968 shares. The largest 10 holders included Aberdeen Group plc, BVF INC/IL, VANGUARD CAPITAL MANAGEMENT LLC, Soleus Capital Management, L.P., Laurion Capital Management LP, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Nantahala Capital Management, LLC, 683 Capital Management, LLC, and Propel Bio Management, LLC. This page lists 71 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.